Pharmaron Beijing Co., Ltd. (300759.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap50.09B
Enterprise Value52.49B
P/E Ratio35.5
PEG Ratio-4.14
Price/Sales Ratio3.47
Price/Book Ratio3.73
Enterprise/Revenue3.79
Enterprise/EBITDA17.13

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.12
Operating Margin0.14
AD

Management Effectiveness

Return On Assets0.06
Return On Equity0.11

Income Statement

Revenue14.1B
Revenue/Share8.05
Gross Profit4.89B
EBITDA3.05B
Net Income1.66B
Diluted EPS0.94

Balance Sheet

Total Cash2.98B
Total Cash/Share1.65
Total Debt7.1B
Total Debt/Equity0.43
Current Ratio1.08
Book Value Per Share9.49

Price History

52-Week Change28.56
52-Week High37.63
52-Week Low21.01
Moving Average 50 Days26.22
Moving Average 200 Days29.12

Statistics

Average Volume41.97M
Shares Outstanding1.48B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.2
Trailing Annual Dividend Yield0.59
Payout Ratio0.32
Last Split Factor3:2
Last Split DateJuly 27, 2023
AD